There is inter-individual variability in which symptoms are relieved in patients with fibromyalgia treated with low dose naltrexone (LDN)

Karin Bruun Plesner, Kirstine Amris, Palle Toft, Henrik Bjarke Vaegter, Morten Rune Blichfeldt-Eckhardt

Research output: Contribution to journalConference abstract in journalResearch

Original languageEnglish
JournalClinical and Experimental Rheumatology
Volume37
Issue numberSuppl. 116
Pages (from-to)S139
Number of pages1
ISSN0392-856X
Publication statusPublished - 2019
EventThe International Congress on Controversies in Fibromyalgia 2019 - Vienna, Austria
Duration: 4. Mar 20195. Mar 2019

Conference

ConferenceThe International Congress on Controversies in Fibromyalgia 2019
Country/TerritoryAustria
CityVienna
Period04/03/201905/03/2019

Cite this